Abstract
Glomangiopericytoma (GPC) is a rare tumour, accounting <0.5% of all nasal cavity tumours. It is classified as borderline malignant to indolent and is associated with perivascular myeloid cells. We report a case of GPC in a woman in her 80s who presented with nasal obstruction. The tumour originated from the nasal septum and was resected via endoscopic sinus surgery. Histopathological examination revealed dense spindle-shaped to oval-shaped mesenchymal cells forming tumour nodules with staghorn-like vessel formation. Immunohistochemical analysis revealed that the tumour cells were positive for α-smooth muscle actin, CD34, β-catenin and cyclin D1, whereas they were negative for STAT6. The percentage of Ki-67-positive cells was approximately 2%. Recent studies have demonstrated a high frequency of β-catenin (CTNNB1) mutations in GPC. We report a case of GPC where identifyingCTNNB1mutations (c.94G>C, p.D32H) was crucial for establishing a definitive diagnosis.
Reference19 articles.
1. Glomangiopericytoma of the nasal cavity
2. Glomangiopericytoma of the Nasal Cavity with CTNNB1 p.S37C Mutation: A Case Report and Literature Review
3. Sinonasal glomangiopericytoma: case report with emphasis on the differential diagnosis;Dandekar;Arch Pathol Lab Med,2010
4. Thompson L , Fanburg-Smith J , Wenig B . Tumours of the nasal cavity and paranasal sinuses, Borderline and low malignant potential tumours of soft tissue, World Health Organization classification of tumours, Pathology and genetics of head and neck tumours. Lyon, France: IARC Press, 2005: 43–4.
5. HEMANGIOPERICYTOMA A VASCULAR TUMOR FEATURING ZIMMERMANNʼS PERICYTES